Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Hair follicles can help diagnose traumatic brain injury quickly and non-invasively.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

Histone modification is key in treating chronic inflammatory skin diseases.

Effective PCOS treatments require targeting specific signaling pathways.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Peptides improve skin health and treatments for hair loss and pregnancy-related skin issues are evolving.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Stress affects skin health, and mental health support is crucial for patients with skin conditions.

ILC1-like cells can independently cause alopecia areata.